Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
Is a |
Product containing paricalcitol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
Is a |
Product containing alcohol (product) |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
Is a |
kombinationsanalgetikum |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Paricalcitol |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with alcohol structure (substance) |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
Is a |
alkohol + paricalcitol + propylenglycol |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Propylene glycol |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Allergenic extract |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
Is a |
Product containing paricalcitol in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|